Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry

PURPOSE: We assessed the systemic treatment choices and outcomes in patients diagnosed with human epidermal growth factor receptor-2-positive (HER2 +) advanced breast cancer (ABC), for the first four lines of systemic therapy and by hormone receptor (HR) status. METHODS: We identified 330 patients d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibragimova, Khava I. E., Geurts, Sandra M. E., Meegdes, Marissa, Erdkamp, Frans, Heijns, Joan B., Tol, Jolien, Vriens, Birgit E. P. J., Dercksen, Marcus W., Aaldering, Kirsten N. A., Pepels, Manon J. A. E., van de Winkel, Linda, Peters, Natascha A. J. B., Teeuwen-Dedroog, Nathalie J. A., Vriens, Ingeborg J. H., Tjan-Heijnen, Vivianne C. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020272/
https://www.ncbi.nlm.nih.gov/pubmed/36635428
http://dx.doi.org/10.1007/s10549-022-06832-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020272/
https://www.ncbi.nlm.nih.gov/pubmed/36635428
http://dx.doi.org/10.1007/s10549-022-06832-9

Ejemplares similares